Photo taken from Penn Medicine
Aug 28, 2024, 14:41
Targeting HER2-low gastric cancer, summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a recent article by on X, adding:
“Targeting HER2-low gastric cancer at ESMO Open.
- Clinicopathological differences
- Available studies and ongoing trials
- Action mechanisms
- IHC criteria different from breast cancer.“
HER2-low gastric cancer: is the subgroup targetable
Authors:
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 13:07
Feb 21, 2025, 13:06
Feb 21, 2025, 13:03
Feb 21, 2025, 13:00
Feb 21, 2025, 12:53
Feb 21, 2025, 12:41
Feb 21, 2025, 12:39